Back
Atara Biotherapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
48
ATRA
Atara Biotherapeutics
Last Price:
11.99
Seasonality Move:
37.22%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- The current trend is moderately bullish and ATRA is experiencing slight selling pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.75 | Buy |
| 20-day SMA: | 10.28 | Buy |
| 50-day SMA: | 9 | Buy |
| 200-day SMA: | 12.83 | Sell |
| 8-day EMA: | 11.89 | Buy |
| 20-day EMA: | 10.7 | Buy |
| 50-day EMA: | 9.64 | Buy |
| 200-day EMA: | 14.91 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 59.39 | Buy |
| Chaikin Money Flow: | -31367 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.45 - 11.57) | Buy |
| Bollinger Bands (100): | (7.32 - 10.36) | Buy |
Atara Biotherapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 12.00 while ATRA 8-day simple moving average is 11.75, which is a Buy signal.
- The stock price of ATRA is 12.00 while Atara Biotherapeutics 20-day SMA is 10.28, which makes it a Buy.
- Atara Biotherapeutics 50-day simple moving average is 9.00 while ATRA share price is 12.00, making it a Buy technically.
- ATRA stock price is 12.00 and Atara Biotherapeutics 200-day simple moving average is 12.83, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
48
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a Sell
The current Atara Biotherapeutics [ATRA] share price is $12.00. The Score for ATRA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
68.09M
Price in USD:
12.00
Share Volume:
107.87K
Atara Biotherapeutics 52-Week Range
52-Week High:
39.50
52-Week Low:
6.50
Sell
48
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?
The Atara Biotherapeutics stock price is 12.00 USD today. -
Will ATRA stock go up or go down?
Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Atara Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 12.00 while ATRA 8-day exponential moving average is 11.89, which is a Buy signal.
- The stock price of ATRA is 12.00 while Atara Biotherapeutics 20-day EMA is 10.70, which makes it a Buy.
- Atara Biotherapeutics 50-day exponential moving average is 9.64 while ATRA share price is 12.00, making it a Buy technically.
- ATRA stock price is 12.00 and Atara Biotherapeutics 200-day simple moving average is 14.91, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $13.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $56.86 per share, and a decrease next year of $3.35 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
- ATRA Moving Average Covergence Divergence (MACD) indicator is 1.08, suggesting Atara Biotherapeutics is a Buy
- Atara Biotherapeutics Relative Strength Index (RSI) is 59.39, which suggest Atara Biotherapeutics is overbought
- The Bollinger Bands (25) for Atara Biotherapeutics is (8.45 - 11.57), which suggest Atara Biotherapeutics is a Buy
- The Bollinger Bands (100) for Atara Biotherapeutics is (7.32 - 10.36), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.